Loading insider details...
Beta
Latest Form 4 (Feb 9, 2026): Grant/Award of 17,500 SGP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 9, 2026 | SpyGlass Pharma, Inc. (SGP) | Grant/Award | 17,500 | n/a |
| Apr 8, 2024 | NGM BIOPHARMACEUTICALS INC (NGM) | Tender of Shares | 3,038 | n/a |
| Feb 3, 2021 | Coherus BioSciences, Inc. (CHRS) | Exercise/Conversion | 7,402 | $74.4K |
| Jan 27, 2021 | Coherus BioSciences, Inc. (CHRS) | Exercise/Conversion | 40,000 | $402.0K |
| Jan 13, 2021 | Coherus BioSciences, Inc. (CHRS) | Grant/Award | 31,250 | n/a |
| Jan 12, 2021 | Coherus BioSciences, Inc. (CHRS) | Tax Withholding | 4,080 | $74.2K |
| Nov 19, 2020 | Coherus BioSciences, Inc. (CHRS) | Sale | 1,995 | $34.9K |
| Oct 16, 2020 | Coherus BioSciences, Inc. (CHRS) | Sale | 6,144 | $116.7K |
| May 22, 2020 | Coherus BioSciences, Inc. (CHRS) | Sale | 1,278 | $22.6K |
| Feb 21, 2020 | Coherus BioSciences, Inc. (CHRS) | Exercise/Conversion | 3,159 | $31.7K |